The estimated Net Worth of Jeremy Stackawitz is at least $2.78 Milion dollars as of 24 May 2021. Mr. Stackawitz owns over 36,988 units of Quotient Ltd stock worth over $56,967 and over the last 10 years he sold QTNT stock worth over $1,756,333. In addition, he makes $969,911 as Chief Commercial Officer at Quotient Ltd.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Mr. Stackawitz QTNT stock SEC Form 4 insiders trading
Jeremy has made over 12 trades of the Quotient Ltd stock since 2015, according to the Form 4 filled with the SEC. Most recently he exercised 36,988 units of QTNT stock worth $14,055 on 24 May 2021.
The largest trade he's ever made was exercising 36,988 units of Quotient Ltd stock on 24 May 2021 worth over $14,055. On average, Jeremy trades about 9,749 units every 100 days since 2015. As of 24 May 2021 he still owns at least 149,914 units of Quotient Ltd stock.
You can see the complete history of Mr. Stackawitz stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Jeremy Stackawitz biography
Jeremy Stackawitz serves as Chief Commercial Officer of the Company. Mr. Stackawitz served as one of our two Presidents prior to assuming his current role in January 2020. Mr. Stackawitz has over 20 years of healthcare industry experience gained through various consulting and industry roles. From 2007 to 2009, Mr. Stackawitz was Worldwide Commercial Director for Immunohematology of Ortho Clinical Diagnostics, a Johnson & Johnson company. Prior to joining Quotient, Mr. Stackawitz held positions from 2006 to 2007 at Therakos, a biotechnology company, from 2004 to 2006 at Ortho Biotech, and from 2000 to 2003 at Purdue Pharma L.P. He also held consulting positions at ISO Healthcare Group (now part of Monitor Group) from 1997 to 2000 and McKinsey & Company in 2003. Mr. Stackawitz received a B.A. in chemistry from Dartmouth College and an M.B.A. from The Wharton School at the University of Pennsylvania.
What is the salary of Jeremy Stackawitz?
As the Chief Commercial Officer of Quotient Ltd, the total compensation of Jeremy Stackawitz at Quotient Ltd is $969,911. There are 2 executives at Quotient Ltd getting paid more, with Franz Walt having the highest compensation of $2,290,340.
How old is Jeremy Stackawitz?
Jeremy Stackawitz is 45, he's been the Chief Commercial Officer of Quotient Ltd since 2020. There are 13 older and no younger executives at Quotient Ltd. The oldest executive at Quotient Ltd is John Wilkerson, 77, who is the Independent Director.
What's Jeremy Stackawitz's mailing address?
Jeremy's mailing address filed with the SEC is C/O QUOTIENT LIMITED, 28 ESPLANADE, ST HELIER, Y9, JE2 3QA.
Insiders trading at Quotient Ltd
Over the last 11 years, insiders at Quotient Ltd have traded over $5,237,327 worth of Quotient Ltd stock and bought 21,364,813 units worth $72,052,006 . The most active insiders traders include Advisors Llcperceptive Life..., Zubeen Shroff a L John Wilkerson. On average, Quotient Ltd executives and independent directors trade stock every 15 days with the average trade being worth of $57,203. The most recent stock trade was executed by Catherine Larue on 31 January 2023, trading 438 units of QTNT stock currently worth $166.
What does Quotient Ltd's logo look like?
Complete history of Mr. Stackawitz stock trades at Quotient Ltd
Quotient Ltd executives and stock owners
Quotient Ltd executives and other stock owners filed with the SEC include:
-
Franz Walt,
Chief Executive Officer, Director -
Edward Farrell,
Chief Operating Officer -
Jeremy Stackawitz,
Chief Commercial Officer -
Peter Buhler,
Chief Financial Officer -
Heino.N.F.M von Prondzynski,
Independent Chairman of the Board -
Frederick Hallsworth,
Independent Director -
Brian McDonough,
Independent Director -
Zubeen Shroff,
Independent Director -
John Wilkerson,
Independent Director -
Catherine Larue,
Independent Director -
Isabelle Buckle,
Independent Director -
Ernest Larnach,
Head - Financial Accounting & Treasury -
Esteban Uriarte,
Chief Manufacturing Operations Officer -
Mohammad El Khoury,
Chief Commercial Officer -
Christian Albrich,
Chief People Officer -
Dr. Christine Ginocchio,
Chief Scientific & Medical Officer -
Dr. Michael Hausmann,
Chief Technology Officer -
Vittoria Bonasso,
Head of Fin., Group Controller & Principal Accounting Officer -
Ali Kiboro,
Chief Financial Officer -
Manuel O. Mendez,
CEO & Director -
Ernest Larnach,
Head of Financial Accounting & Treasury -
Vittoria Bonasso,
See Remarks -
Roland Boyd,
See Remarks -
Thomas A Bologna,
Director -
Sarah A Oconnor,
Director -
Stephen Unger,
Chief Financial Officer -
Partners V Lp Galen Partner...,
-
Deidre Quotient Biodiagnost...,
-
D J Paul E Cowan,
See Remarks -
Sophie Bechu,
Director -
Advisors Llcperceptive Life...,
-
Christopher J Lindop,
EVP -
Ali Kiboro,
Chief Financial Officer -
Manuel O. Mendez,
Chief Executive Officer -
Khoury Mohammad El,
Chief Commercial Officer -
Thomas Aebischer,
Director